ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Atrasentan in Patients With Proteinuric Glomerular Diseases

ClinicalTrials.gov ID: NCT04573920

Public ClinicalTrials.gov record NCT04573920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Basket Study of Atrasentan in Patients With Proteinuric Glomerular Diseases

Study identification

NCT ID
NCT04573920
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
103 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 14, 2021
Primary completion
Jul 1, 2024
Completion
Oct 26, 2026
Last update posted
Aug 10, 2025

2021 – 2026

United States locations

U.S. sites
14
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Kidney Disease Medical Group Glendale California 91206
Academic Medical Research Institute Los Angeles California 90022
North America Research Institute San Dimas California 91773
Stanford U School Of Medicine Stanford California 94305
Colorado Kidney Care Denver Colorado 80230
Northwest Louisiana Nephrology Research Shreveport Louisiana 71101-4440
Tufts Medical Center Boston Massachusetts 02111
Uni of Minnesota Hos and Clinics Minneapolis Minnesota 55455
DaVita Clinical Research Las Vegas Nevada 89146
Mountain Kidney And Hyper Associa Asheville North Carolina 28801
Brookview Hills Research Assoc Winston-Salem North Carolina 27103
Baylor Scott and White Dallas Texas 75246
Prolato Clinical Research Center Houston Texas 77054
Milwaukee Nephrologists SC Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04573920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04573920 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →